Skip to Content

Sartorius AG SARTF

Morningstar Rating
$208.72 −3.96 (1.86%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SARTF is trading at a 478% premium.
Price
$207.87
Fair Value
$882.15
Uncertainty
High
1-Star Price
$226.38
5-Star Price
$427.86
Economic Moat
Wkx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SARTF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$212.67
Day Range
$208.62208.74
52-Week Range
$198.00338.07
Bid/Ask
$181.72 / $197.55
Market Cap
$14.28 Bil
Volume/Avg
56 / 69

Key Statistics

Price/Earnings (Normalized)
106.28
Price/Sales
1.99
Dividend Yield (Trailing)
0.38%
Dividend Yield (Forward)
0.38%
Total Yield
0.38%

Company Profile

Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Large Growth
Total Number of Employees
14,338

Competitors

Valuation

Metric
SARTF
MTD
TMO
Price/Earnings (Normalized)
106.2838.2326.11
Price/Book Value
4.954.73
Price/Sales
1.998.435.14
Price/Cash Flow
12.9535.3425.18
Price/Earnings
SARTF
MTD
TMO

Financial Strength

Metric
SARTF
MTD
TMO
Quick Ratio
1.190.641.19
Current Ratio
2.021.071.70
Interest Coverage
2.3413.344.83
Quick Ratio
SARTF
MTD
TMO

Profitability

Metric
SARTF
MTD
TMO
Return on Assets (Normalized)
2.26%24.64%8.69%
Return on Equity (Normalized)
9.30%18.71%
Return on Invested Capital (Normalized)
4.67%44.22%10.97%
Return on Assets
SARTF
MTD
TMO
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
LjlvbyfghQvzfx$153.4 Bil
Becton Dickinson & Co
BDX
VggqvktwpKvyybz$68.9 Bil
Alcon Inc
ALC
CktshckpVskbys$43.9 Bil
ResMed Inc
RMD
CncxvklkrtTkwhkc$30.2 Bil
Coloplast A/S ADR
CLPBY
XyltvykqrPwkzq$27.3 Bil
West Pharmaceutical Services Inc
WST
MjbzvnlbgwQzbxz$24.4 Bil
The Cooper Companies Inc
COO
MtsznbtcLnmggs$18.2 Bil
Baxter International Inc
BAX
BhpmystrbLlvmsj$17.5 Bil
Hologic Inc
HOLX
PzhxvbybRmvdlf$17.1 Bil
AptarGroup Inc
ATR
FslhbpnkFrpgr$9.7 Bil

Sponsor Center